Gut-Derived Triggers of Multiple Sclerosis

Researchers from Keio University, led by Dr. Shohei Suzuki and Dr. Tomohisa Sujino, have identified a critical gut-CNS axis that triggers multiple sclerosis (MS). Published on June 25, 2026, in Science Immunology, the study reveals that intestinal epithelial cells (IECs) play an active role in autoimmune inflammation by presenting antigens to CD4+ T cells, which then polarize into pathogenic Th17 cells and migrate to the central nervous system. The authors demonstrate that this mechanism is conserved across both experimental autoimmune encephalomyelitis (EAE) mouse models and human patients. By showing that MHC II expression in the gut is essential for the generation of these neuroinflammatory cells, the research shifts the understanding of MS from a purely neurological condition to one with significant gastrointestinal origins. This discovery provides a clear cellular mechanism: IECs upregulate MHC II in response to signals, directly priming T cells in the gut mucosa. These activated Th17 cells subsequently travel through the systemic circulation to the brain and spinal cord, where they attack myelin sheaths, causing the characteristic damage associated with MS. The findings offer promising therapeutic avenues, suggesting that modulating the gut microbiome or inhibiting the antigen-presenting activity of intestinal epithelial cells could serve as novel strategies for treating autoimmune neurological diseases. This research underscores the importance of the gut-brain connection in managing complex autoimmune disorders.